DKSH partners with Roche Diabetes Care to provide Lao patients with innovative medical devices for diabetes management. The agreement follows the Business Unit's strategy of growing its medical device business and to drive into higher value segments and services.
Media release
Vientiane, Laos, August 25, 2021 – DKSH Business Unit Healthcare, Asia's leading partner for healthcare companies seeking to grow their business in Asia and beyond, and Roche Diabetes Care will expand their collaboration with the aim of bringing Accu-Chek digital health solutions to hospitals, clinics and pharmacies across Laos.
Roche Diabetes Care and DKSH have been partnering in Laos since 2015. The extended partnership in the market will assist Roche Diabetes Care in providing cutting-edge medical devices to more healthcare professionals and people with diabetes to proactively manage their condition. DKSH will offer Roche Diabetes Care full-agency services, including registration, marketing and sales, redressing and physical distribution.
Thet Htun Oo, Head of Roche Diabetes Care of Cambodia, Laos and Myanmar, said: “Our vision at Roche Diabetes Care is to help people with diabetes everywhere in the world think less about their daily diabetes routine so they can experience true relief, day and night. This partnership will help people with diabetes in Laos to have better access to high-quality, innovative medical devices. With DKSH's leading marketing and sales competencies supported by regulatory affairs and logistics platforms, as well as its commitment to international quality standards and corporate compliance, we trust in DKSH's capabilities in helping us turn our vision into reality in Laos.”
John Clare, Vice President, Healthcare, DKSH Thailand & Indochina (Myanmar, Cambodia, Laos), said: “We are proud to serve Roche Diabetes Care in marketing and sales as well as logistics and distribution. With a broad reach across our pharmacy and medical channels, from hospitals and clinics to pharmacies, we are committed to driving expansion for Accu-Chek products in Laos. While we drive growth across the market, Roche Diabetes Care can focus on its core competencies – discovery and development of new products – to bring new solutions to those in need.”
For further information, please contact:
DKSH Business Unit Healthcare
Sheena Flannery
Director, Group Communications
Phone +66 2 220 9739
sheena.flannery@dksh.com
About Roche Diabetes Care
Roche Diabetes Care has been pioneering innovative diabetes technologies and services for more than 40 years. More than 5,500 employees in over 100 markets worldwide work every day to support people with diabetes and those at risk to achieve more time in their target ranges and experience true relief from the daily therapy routines.
Being a global leader in integrated Personalized Diabetes Management (iPDM), Roche Diabetes Care collaborates with thought leaders around the globe, including people with diabetes, caregivers, healthcare providers and payers. Roche Diabetes Care aims to transform and advance care provision and foster sustainable care structures. Under the brands RocheDiabetes, Accu-Chek and mySugr, comprising glucose monitoring, insulin delivery systems and digital solutions, Roche Diabetes Care unites with its partners to create patient-centered value. By building and collaborating in an open ecosystem, connecting devices and digital solutions as well as contextualizing relevant data points, Roche Diabetes Care enables deeper insights and a better understanding of the disease, leading to personalized and effective therapy adjustments. For better outcomes and true relief.
Since 2017, mySugr, one of the most popular diabetes management apps, is part of Roche Diabetes Care. For more information, please visit www.rochediabetes.com, www.accu-chek.com and www.mysugr.com.
About DKSH
DKSH’s purpose is to enrich people’s lives. For more than 150 years, we have been delivering growth for companies in Asia and beyond across our Business Units Healthcare, Consumer Goods, Performance Materials and Technology. As a leading Market Expansion Services provider, we offer sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 32,450 specialists, generating net sales of CHF 10.7 billion in 2020. The DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health and over-the-counter (OTC) products as well as medical devices. With around 7,970 specialists, the Business Unit generated net sales of CHF 5.4 billion in 2020. www.dksh.com/hec